129 related articles for article (PubMed ID: 38468843)
1. Clinical Characteristics and Treatment Response of a Novel ELANE Gene Mutation (c.295_303del) in Congenital Neutropenia.
Ning J
Mediterr J Hematol Infect Dis; 2024; 16(1):e2024024. PubMed ID: 38468843
[No Abstract] [Full Text] [Related]
2. [Clinical and genetic analysis of two patients with congenital neutropenia caused by ELANE gene mutation].
Liu H; Liu G; Zhao P; Huang L; Zhou Y; Qiu X; Xu L
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1097-1101. PubMed ID: 32924109
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Characterization of known (c.607G>C) and novel (c.416C>G)
Núñez-Núñez ME; Lona-Reyes JC; López-Barragán B; Cruz-Osorio RM; Gutiérrez-Zepeda BM; Quintero-Ramos A; Becerra-Loaiza DS
Front Immunol; 2023; 14():1194262. PubMed ID: 37795094
[TBL] [Abstract][Full Text] [Related]
4. Screening for ELANE, HAX1 and GFI1 gene mutations in children with neutropenia and clinical characterization of two novel mutations in ELANE gene.
Komvilaisak P; Yudhasompop N; Kanchanakamhaeng K; Hongeng S; Pakakasama S; Anurathapan U; Pongphitcha P; Songdej D; Sasanakul W; Sirachainan N
BMC Pediatr; 2023 Nov; 23(1):592. PubMed ID: 37993852
[TBL] [Abstract][Full Text] [Related]
5. A patient with severe congenital neutropenia harbors a missense ELANE mutation due to paternal germline mosaicism.
Ying Y; Ye J; Chen Y; Chen Q; Chen Y; Lu X; Xi H; Gu F; Pan D; Zhao J
Clin Chim Acta; 2022 Feb; 526():14-20. PubMed ID: 34968504
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics of severe congenital neutropenia caused by novel ELANE gene mutations.
Shu Z; Li XH; Bai XM; Zhang ZY; Jiang LP; Tang XM; Zhao XD
Pediatr Infect Dis J; 2015 Feb; 34(2):203-7. PubMed ID: 25162927
[TBL] [Abstract][Full Text] [Related]
7. Spectrum of
Arun AK; Senthamizhselvi A; Hemamalini S; Edison ES; Korula A; Fouzia NA; George B; Mathews V; Balasubramanian P
J Clin Pathol; 2018 Dec; 71(12):1046-1050. PubMed ID: 30171085
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9-mediated
Nasri M; Ritter M; Mir P; Dannenmann B; Aghaallaei N; Amend D; Makaryan V; Xu Y; Fletcher B; Bernhard R; Steiert I; Hahnel K; Berger J; Koch I; Sailer B; Hipp K; Zeidler C; Klimiankou M; Bajoghli B; Dale DC; Welte K; Skokowa J
Haematologica; 2020 Mar; 105(3):598-609. PubMed ID: 31248972
[TBL] [Abstract][Full Text] [Related]
9. Description of an
Gogou M; Damianidou L; Papageorgiou T; Tragiannidis A; Haidopoulou K; Giannopoulos A; Hatzipantelis E
J Pediatr Genet; 2019 Mar; 8(1):33-37. PubMed ID: 30775052
[TBL] [Abstract][Full Text] [Related]
10. In Silico Analysis Revealed Five Novel High-Risk Single-Nucleotide Polymorphisms (rs200384291, rs201163886, rs193141883, rs201139487, and rs201723157) in
Shinwari K; Bolkov MA; Yasir Akbar M; Guojun L; Deryabina SS; Tuzankina IA; Chereshnev VA
ScientificWorldJournal; 2022; 2022():3356835. PubMed ID: 35571273
[TBL] [Abstract][Full Text] [Related]
11. Inducible expression of a disease-associated
Garg B; Mehta HM; Wang B; Kamel R; Horwitz MS; Corey SJ
J Biol Chem; 2020 May; 295(21):7492-7500. PubMed ID: 32299910
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of ELANE mutations and their implications in severe congenital and cyclic neutropenia.
Germeshausen M; Deerberg S; Peter Y; Reimer C; Kratz CP; Ballmaier M
Hum Mutat; 2013 Jun; 34(6):905-14. PubMed ID: 23463630
[TBL] [Abstract][Full Text] [Related]
13. Novel
Jia Y; Yue C; Bradford K; Qing X; Panosyan EH; Gotesman M
J Pediatr Genet; 2020 Sep; 9(3):203-206. PubMed ID: 32714623
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9-Mediated ELANE Mutation Correction in Hematopoietic Stem and Progenitor Cells to Treat Severe Congenital Neutropenia.
Tran NT; Graf R; Wulf-Goldenberg A; Stecklum M; Strauß G; Kühn R; Kocks C; Rajewsky K; Chu VT
Mol Ther; 2020 Dec; 28(12):2621-2634. PubMed ID: 32822592
[TBL] [Abstract][Full Text] [Related]
15. Severe congenital neutropenia in a multigenerational family with a novel neutrophil elastase (ELANE) mutation.
van de Vosse E; Verhard EM; Tool AJ; de Visser AW; Kuijpers TW; Hiemstra PS; van Dissel JT
Ann Hematol; 2011 Feb; 90(2):151-8. PubMed ID: 20803142
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Gene Editing versus a Neutrophil Elastase Inhibitor as Potential Therapies for
Makaryan V; Kelley M; Fletcher B; Archibald I; Poulsen T; Dale D
J Cell Immunol; 2022; 4(1):19-28. PubMed ID: 36052149
[TBL] [Abstract][Full Text] [Related]
17. ELANE mutant-specific activation of different UPR pathways in congenital neutropenia.
Nustede R; Klimiankou M; Klimenkova O; Kuznetsova I; Zeidler C; Welte K; Skokowa J
Br J Haematol; 2016 Jan; 172(2):219-27. PubMed ID: 26567890
[TBL] [Abstract][Full Text] [Related]
18. Four novel ELANE mutations in patients with congenital neutropenia.
Kurnikova M; Maschan M; Dinova E; Shagina I; Finogenova N; Mamedova E; Polovtseva T; Shagin D; Shcherbina A
Pediatr Blood Cancer; 2011 Aug; 57(2):332-5. PubMed ID: 21425445
[TBL] [Abstract][Full Text] [Related]
19. Cyclic Neutropenia From a Novel Mutation Ala57Asp of ELANE: Phenotypic Variability in Neutropenia From Mutated Ala57 Residue.
Park CH; Park S; Kim YJ; Kim SH; Kim HJ
J Pediatr Hematol Oncol; 2020 May; 42(4):e231-e234. PubMed ID: 31658467
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of mutations in ELANE, GFI1, HAX1, SBDS, WAS and G6PC3 in patients with severe congenital neutropenia.
Xia J; Bolyard AA; Rodger E; Stein S; Aprikyan AA; Dale DC; Link DC
Br J Haematol; 2009 Nov; 147(4):535-42. PubMed ID: 19775295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
